Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Thromboembolism and CYP4F2[original query] |
|---|
| Genetic determinants of warfarin dosing in the Han-Chinese population. Pharmacogenomics 2009 Dec 10 (12): 1905-13. Lee M T Michael, Chen Chien-Hsiun, Chou Ching-Heng, Lu Liang-Suei, Chuang Hui-Ping, Chen Ying-Ting, Saleem Amir N, Wen Ming-Shien, Chen Jin-Jer, Wu Jer-Yuarn, Chen Yuan-Tso |
| A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism. Thrombosis research 2010 Jun 125 (6): e259-64. Wells P S, Majeed H, Kassem S, Langlois N, Gin B, Clermont J, Taljaard |
| Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients. Thrombosis research 2012 Sep 130 (3): 435-40. Liu Yu, Yang Jie, Xu Qiang, Xu Bin, Gao Lei, Zhang Yuxiao, Zhang Yan, Wang Hongjuan, Lu Caiyi, Zhao Yusheng, Yin To |
| Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial. Trials 2012 Dec 13 (1): 1. Carcas AJ, Borobia AM, Velasco M, Abad-Santos F, Díaz MQ, Fernández-Capitán C, Ruiz-Giménez N, Madridano O, Sillero PL |
| [Personalized drug therapy-directed clinical pharmacology research based on genetic polymorphisms and pharmacokinetics analysis]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2013 133 (10): 1079-85. Hayashi Hide |
| Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm. Pharmacogenetics and genomics 2014 Oct 24 (10): 501-13. Jiménez-Varo Enrique, Cañadas-Garre Marisa, Gutiérrez-Pimentel María J, Calleja-Hernández Miguel |
| [Impact of six genetic polymorphisms on Warfarin maintenance dose variation in Chinese Han population]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2014 Jun 31 (3): 367-71. Lou Ying, Han Lulu, Li Yan, Zhang Xiaoxing, Liu Zhihong, Tang Min, Yu Haiwen, Wang Wei, Xu Jianping, Liu Hong, Li Yis |
| Pharmacogenetics role in the safety of acenocoumarol therapy. Thrombosis and haemostasis 2014 Sep 112 (3): 522-36. Jiménez-Varo E, Cañadas-Garre M, Henriques C I, Pinheiro A M, Gutiérrez-Pimentel M J, Calleja-Hernández M |
| Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms. Vascular pharmacology 2018 Feb . Bryk Agata Hanna, Wypasek Ewa, Plens Krzysztof, Awsiuk Magdalena, Undas Anet |
| Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2020 4 26 1076029620909154. Rojo Mario, Roco Angela Margarita, Suarez Marcelo, Lavanderos Maria Alejandra, Verón Gabriel, Bertoglia Maria Paz, Arredondo Annabella, Nieto Elena, Rubilar Juan Carlos, Tamayo Francisca, Cruz Daniela, Muñoz Jessica, Bravo Gabriela, Salas Patricio, Mejías Fanny, Véliz Paulo, Godoy Gerald, Varela Nelson Miguel, Llull G, Quiñones Luis Ab |
| Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial. Journal of clinical medicine 2021 7 10 (13): . Tong Hoi Yan, Borobia Alberto M, Quintana-Díaz Manuel, Fabra Sara, González-Viñolis Manuel, Fernández-Capitán Carmen, Rodriguez-Dávila María A, Lorenzo Alicia, López-Parra Ana María, Ruiz-Giménez Nuria, Abad-Santos Francisco, Suarez Carmen, Madridano Olga, Gómez-Cerezo Jorge Francisco, Llamas Pilar, Baeza-Richer Carlos, Arroyo-Pardo Eduardo, Carcas Antonio J, The Pgx-Ace Spanish Investigators Grou |
- Page last reviewed:Feb 1, 2024
- Content source: